维普中文期刊产品整合服务
26篇 您的检索式:作者名="Lara P Jr"
    题名 作者 年代 出处 被引量
1Phase Ⅱ trial of irinote-ean/cisplatin compared with etoposide/cisplatin in extersive-stage small-cen lung cancer:clinical and pharmarogenomic results from SWOG SO124 显示文摘Lara P N Jr Natale R Crouley J 2009J Clin Onco12009,27,15:1
2Activity of highdose toremifene plus eispLatin in platinum-treated nonsmall-cell lung cancer:,a phase Ⅱ California Cancer Consortium Trial显示文摘Lara P Jr Gandara DR Longmate J 2001Cancer Chemother Pharmacol2001,48,1:1
3Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive - stage small - cell lung cancer: clinical and pharmacogenomic results from SWOG S0124 显示文摘Lara P N Jr Natale R Crowley J 2009J Clin Oncol2009,27,15:1
4Activity of high-dose toremifene plus cisplatin in platinumol/L-treated non-small-cell lung cancer:a phase Ⅱ california cancer consortiumol/L trial显示文摘Lara Jr P N Gandara D R Longmate J 2001Cancer Chemother Pharacol2001,48,:1
5Tip dieback of mango (Mangifera indica) caused by Botryosphaeria ribis显示文摘Ramos L J Lara S P McMillan R T Jr 1991Plant disease1991,75,:1
6SU5416 plus inter- feron alpha in advanced renal cell carcinoma a phase imaging cor- relates of angiogenesis inhibition 显示文摘LARA P N JR QUINN D I MARGOLIN K 2006Clin Cancer Res2006,9,130:1
7Phase II clinical trial of the epothilone B analog, ixabepilone, in patients with non small-cell lung cancer whose tumors have failed first-line platinum-based chemotherapy显示文摘VANSTEENKISTE J LARA P N Jr LE CHEVALIER T 2007J Clin Oncol2007,25,23:1
8Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer显示文摘Petrylak D P Tangen C M Hussain M H Lara P N Jr Jones J A Taplin M E 2004N Engl J Med2004,351,:1
9Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer:results from Southwest Oncology Group randomized trials显示文摘Lara P N Jr Redman M W Kelly K 2008J Clin Oncol2008,26,3:1
10Tip dieback of mango (Mangifera indica) caused byBotryosphaeria ribis显示文摘Ramos L J Lara S P McMillan R T Jr 1991Plant Disease1991,75,3:1
11Beyond antiepidermal growth factor receptors and antiangiogenesis strategies for non-small cell lung cancer:exploring a new frontier显示文摘SANGHA R LARA P N Jr MACK P C 2009Curr Opin Oncol2009,21,2:1
12Sorafenih with interferon alfa-2b as first line treatment of advanced renal carcinoma: a phase lI study of the Southwest Oncology Group 显示文摘Ryan C W Goldman B H Lara P N Jr Mack P C Beer T M Tangen C M 2007J Clin Oncol2007,25,:1
13Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer:a phase II California Cancer Consortium Trial显示文摘Lara P Jr Gandara DR Longmate J 2001Cancer Chemother Pharmacol2001,48,1:1
14Phase Ⅲ trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer:clinical and pharmacogenomic results from SWOG S0124显示文摘Lara P N Jr Natale R Crowley J 2009J Clin Oncol2009,2027,15:1
15Activity of high-dose toremifene plus cisplatin in platinum-treated nonsmall-cell-lung cancer:a phase of Ⅱ California Cancer Consortium Trial 显示文摘Lara P Jr Gandara D R Gumerlocr P H 2001Cancer Chemother Pharmacol2001,48,:1
16Activity of high-dose toremifene plus cisplatin in platinum-treated non-small cell lung cancer: a phase Ⅱ California Cancer Consortium Trial 显示文摘LARA P N JR GANDARA D R LONGMATE J 2001Cancer Chemother Pharacol2001,48,1:1
17High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer:targeted plasma levels are achievable clinically 显示文摘Lara P Jr Gandara D R Wurz G T 1998Cancer Che mother Pharmacol1998,42,6:1
18Retreatment of recurrent invasire thymoma with platinum,doxorubicin,and cyclophosphamide显示文摘Lara PN Jr Bonomi PD Faber L P 1996Chest1996,110,:1
19Activity of high-doss toremifene plus cisplatin in platinum-treated non-small-cell lung cancer:a phase Ⅱ California Cancer Consortium Trial显示文摘Lara P N Jr G andara D R Longmate J 0,,01:1
20High-dose toremifene as a cisplatin modulator in metastatic non-small lungcancer:targeted plasma levels are achievable clinically显示文摘 Gandara DR Wurz GT 1998Cancer Chemother Pharmacol1998,42,6:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费